Hepatocyte growth factor (HGF) for a cell-signal-based therapy during acute and chronic liver diseases

Current Signal Transduction Therapy

Volumn 6, Issue 2, 2011, Pages 200-209

  Oka, Kiyomasa ^a   Fukuta, Kazuhiro ^a   Mizuno, Shinya ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

c Met; Growth factor therapy; Hepatitis and cirrhosis; HGF; Liver regeneration

Indexed keywords

RECOMBINANT SCATTER FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ACUTE HEPATITIS; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL THERAPY; CHOLESTATIC HEPATITIS; FATTY LIVER; HEPATITIS; LIPIDOSIS; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER ISCHEMIA; LIVER NECROSIS; LIVER REGENERATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; SEPSIS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 79957959166     PISSN: 15743624     EISSN: 15743624     Source Type: Journal    
DOI: 10.2174/157436211795659973     Document Type: Article

References (72)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9. (Pubitemid 14073577)
2. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3. (Pubitemid 19277521)
3. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3: 67-85. (Pubitemid 121006993)
4. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncog 1992; 3: 27-54.
5. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1993; 1155: 357-71. (Pubitemid 24012300)
6. Zarnegar R. Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-80.
7. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995; 345: 293-5.
8. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4. (Pubitemid 21926175)
9. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, mortality, and more. Nature Rev Mol Cell Biol 2003; 4: 915-25.
10. Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008; 27: 85-94.
11. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404-410. (Pubitemid 28458706)
12. Barros EJ, Santos OF, Matsumoto K, Nakamura T, Nigam SK. Differential tubulogenic and branching morphogenetic activities of growth factors: implications for epithelial tissue development. Proc Natl Acad Sci USA 1995; 92: 4412-6.
13. Schmidt C, Bladt F, Goedecke S, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699-702.
14. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 588-610.
15. Mizuno S, Nakamura T. Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis. Regen Med 2007; 2: 161-70. (Pubitemid 46831077)
16. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16: 1227-35.
17. Burr AW, Toole K, Chapman C, et al. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J Pathol 1998; 185: 298-302. (Pubitemid 28320052)
18. Borowiak M, Garratt AN, Wustefeld T, et al. Met provides essential signals for liver regeneration. Proc Natl Acad Sci USA 2004; 101: 10608-13. (Pubitemid 38955789)
19. Giebeler A, Boekschoten MV, Klein C, et al. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology 2009; 137: 297-308.
20. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 1989; 165: 1229-34. (Pubitemid 20029839)
21. Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun1990; 173: 42-7.
22. Kinoshita T, Hirao S, Matsumoto K, Nakamura T. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem Biophys Res Commun 1991; 177: 330-5.
23. Matsumoto K, Okazaki H, Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 1992; 188: 235-43.
24. Khan KN, Masuzaki H, Fujishita A, et al. Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis. Hum Reprod 2005; 20: 2715-23. (Pubitemid 41487625)
25. Hashigasako A, Machide M, Nakamura T, Matsumoto K, Nakamuram T. Bi-directional regulation of Ser-985 phosphorylation of cmet via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004; 279: 26445-52. (Pubitemid 38798797)
26. Nakamura T, Tomita Y, Ichihara A. Density-dependent growth control of adult rat hepatocytes in primary culture. J Biochem 1983; 94: 1029-35. (Pubitemid 14227236)
27. Machide M, Hashigasako A, Matsumoto K, Nakamura T. Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR proteintyrosine phosphatase. J Biol Chem 2006; 281: 8765-72. (Pubitemid 43847982)
28. Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003; 327: 1-23. (Pubitemid 35447813)
29. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998; 244: 683-90. (Pubitemid 28418128)
30. Wang X, DeFrances MC, Dai Y, et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 2002; 9: 411-21. (Pubitemid 34195565)
31. Schulze-Bergkamen H, Brenner D, Krueger A, et al. Hepatocyte growth factor induces Mcl-1 in primry human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology 2004; 39: 645-54. (Pubitemid 38337644)
32. Moumen A, Ieraci A, Patané S, et al. Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Aktdependent manner. Hepatology 2007; 45: 1210-7. (Pubitemid 46775784)
33. Tsuboi S. Elevation of glutathione level in rat hepatocytes by hepatocyte growth factor via induction of gamma-glutamylcysteine synthetase. J Biochem 1999; 126: 815-20.
34. Oe S, Hirose T, Fujii H, et al. Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia- reperfusion injury in rats. J Hepatol 2001; 34: 832-9. (Pubitemid 32595182)
35. Webster CR, Anwer MS. Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 2001; 33: 608-15. (Pubitemid 32185223)
36. Mizuno S, Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 2005; 166: 1895-905. (Pubitemid 40734411)
37. Tahara M, Matsumoto K, Nukiwa T, Nakamura T. Hepatocyte gowth factor leads to recovery from alcohol-induced fatty liver in rats. J Clin Invest 1999; 103: 313-20. (Pubitemid 29069980)
38. Sugimoto T, Yamashita S, Ishigami M, et al. Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. J Hepatol 2002; 36: 157-62. (Pubitemid 34146421)
39. Kamimoto M, Mizuno S, Nakamura T. Reciprocal regulation of IL-6 and IL-10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia. Int J Mol Med 2009; 24: 161-70.
40. Border WA, Noble NA. Transforming growth factor-beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-92. (Pubitemid 24333194)
41. Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R, Gressner AM. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 2008: 23; 1024-35. (Pubitemid 352019381)
42. Bessho K, Mizuno S, Matsumoto K, Nakamura T. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis. Am J Physiol 2003 284: F1171-80. (Pubitemid 36578444)
43. Kim HW, Matsumoto K, Bessho K, Nakamura T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 2005; 166: 1017-28. (Pubitemid 40524427)
44. Xia JL, Dai C, Michalopoulos GK, Liu Y. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006; 168: 1500-12.
45. Mizuno S, Matsumoto K, Li MY, Nakamura T. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. FASEB J 2005; 19: 580-2. (Pubitemid 40471250)
46. Ono M, Sawa Y, Mizuno S, et al. Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats. Circulation 2004; 896-2902.
47. Arakaki N, Kawakami S, Nakamura O, et al. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 1995; 22: 1728-34.
48. Kosai K, Matsumoto K, Funakoshi H, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999; 30: 151-9. (Pubitemid 29300581)
49. Seto S, Kaido T, Yamaoka S, et al. Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res 1998; 80: 194-9. (Pubitemid 29019669)
50. Li Z, Mizuno S, Nakamura T. Anti-necrotic and anti-apoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am J Physiol 2007; 292: G639-G46.
51. Matsuda Y, Matsumoto K, Tsuchida T, Nakamura T. Hepatocyte growth factor prevents liver cirrhosis caused by dimethylnitrosamine in rats. J Biochem 1995; 118: 643-9.
52. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Medicine 1999; 5: 226-30. (Pubitemid 29068532)
53. Matsuda Y, Matsumoto K, Yamada A, et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997; 26: 81-9. (Pubitemid 27280310)
54. Masunaga H, Fujise N, Shiota A, et al. Preventive effects of the deleted form of hepatocyte growth factor against liver injuries. Eur J Pharmacol 1998; 342: 267-79. (Pubitemid 28149979)
55. Sato M, Kakubari M, Kawamura M, et al. The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol 2000; 59: 681-90. (Pubitemid 30085450)
56. Tashiro H, Fudaba Y, Itoh H, et al. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats. Transplantation 2003; 76: 761-5. (Pubitemid 37140215)
57. Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112: 160-9. (Pubitemid 38056352)
58. Miyazaki M, Akiyama I, Sakaguchi M, et al. Improved conditions to induce hepatocytes from rat bone marrow cells in culture. Biochem Biophys Res Commun 2002; 298: 24-30. (Pubitemid 35205382)
59. Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta JA. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 2003; 101: 4201-8. (Pubitemid 36857905)
60. 4-injured rats. J Hepatol 2006; 44: 742-8.
61. Marino G, Rustgi VK, Salzberg G, et al. Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease. Aliment Pharmacol Ther 2002; 16: 235-42. (Pubitemid 34146364)
62. Cui YL, Meng MB, Tang H, et al. Recombinant human hepatocyte growth factor for liver failure. Contemp Clin Trials 2008; 29: 696-704.
63. Ido A, Moriuchi A, Marusawa H, et al. Translational research on HGF: A phase I/II study of recombinant human HGF for the treatment of fulminant hepatic failure. Hepatol Res 2008; 38: S88-S92.
64. Nomi T, Shiota G, Isono M, Sato K, Kawasaki H. Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats. Biochem Biophys Res Commun 2000; 278: 338-43.
65. Kondo H, Tani T, Kodama M. Effects of deletion-type human hepatocyte growth factor on murine septic model. J Surg Res 1999; 85: 88-95. (Pubitemid 29389972)
66. Yoshikawa A, Kaido T, Seto S, et al. Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats. J Surg Res 1998; 78: 54-9. (Pubitemid 28419194)
67. Oe S, Fukunaka Y, Hirose T, Yamaoka Y, Tabata Y. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release 2003; 88: 193-200. (Pubitemid 36287337)
68. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636-42. (Pubitemid 26296009)
69. Matsuno Y, Iwata H, Umeda Y, et al. Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis. Gene Ther 2003; 10: 1559-66. (Pubitemid 37063261)
70. Sakakura Y, Kaibori M, Oda M, et al. Recombinant human hepatocyte growth factor protects the liver against hepatic ischemia and reperfusion injury in rats. J Surg Res 2000; 92: 261-6. (Pubitemid 30612641)
71. Uchiyama H, Yanaga K, Nishizaki T, et al. Effects of deletion variant of hepatocyte growth factor on reduced-size liver transplantation in rats. Transplantation 1999; 68: 39-44. (Pubitemid 29352827)
72. Ikegami T, Nishizaki T, Uchiyama H, et al. Deletion variant of hepatocyte growth factor prolongs allograft survival after liver transplantation in rats. Surgery 1999; 125: 602-7. (Pubitemid 29265001)